Vor Biopharma (VOR) Total Current Liabilities (2020 - 2026)

Vor Biopharma (VOR) has 7 years of Total Current Liabilities data on file, last reported at $16.1 million in Q1 2026.

• On a quarterly basis, Total Current Liabilities fell 3.89% year-over-year to $16.1 million in Q1 2026; TTM through Mar 2026 was $16.1 million, a 3.89% decrease from a year earlier, with the FY2025 full-year figure at $25.2 million, up 35.24% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $16.1 million, down from $25.2 million in the prior quarter.
• Over the last five years, Total Current Liabilities for VOR reached as high as $58.8 million in Q2 2025 and fell as low as $11.1 million in Q3 2022.
• Historically, Total Current Liabilities has averaged $18.0 million across 5 years, with a median of $15.4 million in 2023.
• Across the five-year window, Total Current Liabilities tumbled 30.68% in 2023 and jumped 325.86% in 2025, its largest moves.
• Year by year, Total Current Liabilities stood at $13.1 million in 2022, then climbed by 18.7% to $15.6 million in 2023, then gained by 19.52% to $18.6 million in 2024, then soared by 35.24% to $25.2 million in 2025, then tumbled by 36.13% to $16.1 million in 2026.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $16.1 million in Q1 2026, $25.2 million in Q4 2025, and $18.8 million in Q3 2025.